Phase II Trial of Nanoparticle Albumin-Bound (Nab) Paclitaxel/Cyclophosphamide in Early-Stage Breast Cancer (With Trastuzumab in HER2 Positive Patients).
Phase of Trial: Phase II
Latest Information Update: 06 Sep 2013
At a glance
- Drugs Cyclophosphamide (Primary) ; Paclitaxel (Primary) ; Trastuzumab (Primary)
- Indications Early breast cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2011 Actual end date (September 2010) added as reported by ClinicalTrials.gov.